US strikes over the past few nights have damaged 23 drug and medical supply companies across Iran, including 15 drug manufacturing facilities and eight companies responsible for drug distribution and supply, according to Iran's Food and Drug Administration, cited by Tasnim.
￭ The attacks have disrupted pharmaceutical operations and raised concerns about domestic manufacturing, procurement of raw materials and healthcare supply chains, which have already been weakened by US economic sanctions.
￭ Out of approximately 700 essential and vital medicines required by the country, 37 face supply challenges, some of which stem from existing restrictions on procurement and importation.